Literature DB >> 8372711

Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging.

C Andersen1, J C Haselgrove, S Doenstrup, J Astrup, C Gyldensted.   

Abstract

Peritumoural brain oedema is a prominent feature of malignant brain tumours. Glucocorticoids diminish the neurological symptoms and signs caused by the oedema and reduce the abnormally high cerebral water content. The exact mechanisms of action of the glucocorticoids are unknown. The present study investigates the influence of dexamethasone on NMR relaxation time T1 in peritumoural oedema in 13 patients with gliomas. It is shown that NMR T1 images can be used as a potent monitor of brain oedema, and that dexamethasone significantly reduces mean T1 after 1, 3, and 7 days of treatment by 2%, 6%, and 13% respectively. Using an image histogram analysis technique the term "super-oedema" was defined as the 50% of the total oedema area with the highest T1, corresponding to the highest water content. It is shown, that with this technique the treatment effect of steroids on super-oedema was a reduction of 13%, 33%, and 57% after 1, 3, and 7 days of treatment respectively. The mean change after 24 hours of treatment was statistically significant (p < 0.01). The method can be used in all situations where the anti-oedematous effect of a given treatment is to be monitored.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372711     DOI: 10.1007/bf01405532

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  In vivo characterization of infusion edema by magnetic resonance imaging.

Authors:  P P Fatouros; S Inao; A Marmarou; K A Kraft
Journal:  Adv Neurol       Date:  1990

2.  Human malignant gliomas secrete a factor that increases brain capillary permeability: role in peritumoural brain oedema.

Authors:  T Ohnishi; T Hayakawa; W R Shapiro
Journal:  Acta Neurochir Suppl (Wien)       Date:  1990

3.  Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature.

Authors:  R L Kamman; K G Go; W Brouwer; H J Berendsen
Journal:  Magn Reson Med       Date:  1988-03       Impact factor: 4.668

4.  RLSQ: T1, T2, and rho calculations, combining ratios and least squares.

Authors:  J J In den Kleef; J J Cuppen
Journal:  Magn Reson Med       Date:  1987-12       Impact factor: 4.668

5.  Evaluation of brain edema using magnetic resonance proton relaxation times.

Authors:  Y Fu; K Tanaka; S Nishimura
Journal:  Adv Neurol       Date:  1990

6.  Effects of methylprednisolone on peritumoral brain edema. A quantitative autoradiographic study.

Authors:  K Yamada; Y Ushio; T Hayakawa; N Arita; N Yamada; H Mogami
Journal:  J Neurosurg       Date:  1983-10       Impact factor: 5.115

Review 7.  A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic?

Authors:  P A Bottomley; C J Hardy; R E Argersinger; G Allen-Moore
Journal:  Med Phys       Date:  1987 Jan-Feb       Impact factor: 4.071

8.  Formation and resolution of white matter oedema in various types of brain tumours.

Authors:  U Ito; H Tomita; O Tone; T Shishido; H Hayashi
Journal:  Acta Neurochir Suppl (Wien)       Date:  1990

9.  Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone.

Authors:  B A Bell; M A Smith; D M Kean; C N McGhee; H L MacDonald; J D Miller; G H Barnett; J L Tocher; R H Douglas; J J Best
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

10.  Blood flow and regulation of blood flow in experimental peritumoral edema.

Authors:  K A Hossman; M Blöink
Journal:  Stroke       Date:  1981 Mar-Apr       Impact factor: 7.914

View more
  5 in total

1.  Early changes in peritumorous oedema and contralateral white matter after dexamethasone: a study using proton magnetic resonance spectroscopy.

Authors:  P Chumas; B Condon; D Oluoch-Olunya; S Griffiths; D Hadley; G Teasdale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

2.  Glucocorticoid treatment of brain tumor patients: changes of apparent diffusion coefficient values measured by MR diffusion imaging.

Authors:  Sosuke Minamikawa; Kinuko Kono; Keiko Nakayama; Hiroyuki Yokote; Takahiko Tashiro; Akimasa Nishio; Mitsuhiro Hara; Yuichi Inoue
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

3.  Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches.

Authors:  Manus J Donahue; Jaishri O Blakeley; Jinyuan Zhou; Martin G Pomper; John Laterra; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

Review 4.  Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.

Authors:  Ellie Edlmann; Susan Giorgi-Coll; Peter C Whitfield; Keri L H Carpenter; Peter J Hutchinson
Journal:  J Neuroinflammation       Date:  2017-05-30       Impact factor: 8.322

5.  Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase.

Authors:  Ellie Edlmann; Eric P Thelin; Karen Caldwell; Carole Turner; Peter Whitfield; Diederik Bulters; Patrick Holton; Nigel Suttner; Kevin Owusu-Agyemang; Yahia Z Al-Tamimi; Daniel Gatt; Simon Thomson; Ian A Anderson; Oliver Richards; Monica Gherle; Emma Toman; Dipankar Nandi; Phillip Kane; Beatrice Pantaleo; Carol Davis-Wilkie; Silvia Tarantino; Garry Barton; Hani J Marcus; Aswin Chari; Antonio Belli; Simon Bond; Rafael Gafoor; Sarah Dawson; Lynne Whitehead; Paul Brennan; Ian Wilkinson; Angelos G Kolias; Peter J A Hutchinson
Journal:  Sci Rep       Date:  2019-04-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.